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Introduction
Systemic-onset Juvenile Idiopathic Arthritis (SOJIA) is
not rare in India, where biotherapies are unaffordable.
Data on its course, outcome and complications are
scarce.
Objectives
We describe this data in a monocentric cohort of
53 patients, followed up for at least 3 years.
Methods
A pre-biologic era Italian study where one of the authors
(RC) had participated, formed a template and comparator.
After ethics committee approvals and consents, a cohort
of 53 consecutive patients diagnosed with SOJIA before
10-2009 using the ILAR criteria were followed up until
09-2012. At each visit, general (including growth para-
meters) and articular examination, laboratory parameters
(CBC, ESR , liver enymes) and ongoing treatment were
entered in a customized database.Course was classified as
monocyclic (single episode) polycyclic (multiple episodes
with remissions in between) and persistent (continuous
articular/systemic disease activity). At last visit, outcome
was studied with respect to remission (Wallace criteria)
and Steinbrocker functional classification. Juvenile Arthritis
Damage Index (JADI) measured on 20/53 patients.
Results
In the 53 patients studied (35-M,18-F), 21 constituted
an inceptional cohort and 32 were referred to our center
with prior diagnosis / treatment. Mean age at diagnosis
was 6.3 years (range 4m-14y), mean follow up period
was 5.5 years (range 3-10 years) and mean time from
onset of symptoms to diagnosis was 8.5 months (range
2 wks-7 years). Forty four patients received NSAIDs, 52
oral corticosteroids and 34 required pulses of methyl-
prednisolone with intra-articular triamcinolone aceto-
nide being used in 14. Methotrexate was used in
50 patients, other DMARDs in 25(hydroxychloroquine,
leflunomide, cyclosporine, cyclophosphamide, thalido-
mide) and 5 received biologics briefly (etanercept-2,
tocilizumab-3). Nine had a monocyclic, 31 intermittent
and 13 persistent course. At last visit, 9/9 patients of the
monocyclic group,17/31 in the intermittent group and
3/13 in the persistent group were in remission. Patients
diagnosed within 6 months from disease onset were
more likely to have a monocyclic / intermittent than a
persistent course, compared to those diagnosed later.
33/53 suffered from complications of the disease and
/or drug. MAS was observed in 5 and death occurred in
1, due to hepatic encephalopathy complicating viral
hepatitis A.Three required orthopedic surgeries for resi-
dual deformities. All children in the monocyclic group
belonged to Steinbrocker class 1 at last visit. Of 31 in
the intermittent group, 27 belonged to class 1 and 4 to
class 2. In 13 of the persistent group, 7 belonged to
class 1, 4 to class 2 and 2 to class 3. JADI was per-
formed on 20/53 patients.9 had significant articular
damage. The range of JADI-Articular was 0-25/72
(median-6) and the range of JADI- Extra-articular was
0-4/17 (median-1).
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Conclusion
Drug regimens comprising NSAIDs, steroids (oral/intra-
articular),methotrexate and other DMARDs still form
the mainstay of SOJIA treatment in India in contrast
with the developed world where biologics have come to
the forefront. As a result 33/53(65%) patients showed
drug and/or disease-related complications. Delay in
diagnosis is a major problem and is associated with a
persistent course. Children with monocyclic and inter-
mittent course have the best functional outcome. JADI
is an easily applicable bedside tool to evaluate both
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